Gene · 623
Papers2,473
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,473
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural biology of human GPCR drugs and endogenous ligands - insights from NMR spectroscopy. | Methods | 2020 | 32911074 | PubTator, text mining | PubMed |
| Epigenome-wide association study for transgenerational disease sperm epimutation biomarkers following ancestral exposure to jet fuel hydrocarbons. | Reprod Toxicol | 2020 | 32905848 | PubTator, text mining | PubMed |
| Kinins and Their Receptors in Infectious Diseases. | Pharmaceuticals (Basel) | 2020 | 32867272 | PubTator, text mining | PubMed |
| Effect of alkylglycerone phosphate synthase on the expression levels of lncRNAs in glioma cells and its functional prediction. | Oncol Lett | 2020 | 32863899 | PubTator, text mining | PubMed |
| Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key? | Front Immunol | 2020 | 32849666 | PubTator, text mining | PubMed |
| Bradykinin B2 Receptor Signaling Increases Glucose Uptake and Oxidation: Evidence and Open Questions. | Front Pharmacol | 2020 | 32848770 | PubTator, text mining | PubMed |
| Safety and Efficacy of Ultra-Low-Dose Intracavernosal Adrenaline for Intraoperative Penile Erection in Transurethral Surgeries under Spinal Anesthesia. | Anesth Essays Res | 2020 | 32843785 | PubTator, text mining | PubMed |
| Angioedema and urticaria in a COVID-19 patient: A case report and review of the literature. | JAAD Case Rep | 2020 | 32837990 | PubTator, text mining | PubMed |
| Does hereditary angioedema make COVID-19 worse? | World Allergy Organ J | 2020 | 32834893 | PubTator, text mining | PubMed |
| In Vitro Modeling of Bradykinin-Mediated Angioedema States. | Pharmaceuticals (Basel) | 2020 | 32824891 | PubTator, text mining | PubMed |
| A Systematic Review of Molecular Imaging Agents Targeting Bradykinin B1 and B2 Receptors. | Pharmaceuticals (Basel) | 2020 | 32824565 | PubTator, text mining | PubMed |
| Genes encoding ACE2, TMPRSS2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes. | J Mol Cell Cardiol | 2020 | 32818486 | PubTator, text mining | PubMed |
| Bradykinin 1 Receptor Antagonist BI1026706 Does Not Reduce Central Retinal Thickness in Center-Involved Diabetic Macular Edema. | Transl Vis Sci Technol | 2020 | 32818112 | PubTator, text mining | PubMed |
| Clinical, genomics and networking analyses of a high-altitude native American Ecuadorian patient with congenital insensitivity to pain with anhidrosis: a case report. | BMC Med Genomics | 2020 | 32807182 | PubTator, text mining | PubMed |
| Inotropic and Mechanical Support of Critically Ill Patient after Cardiac Surgery. | Med Arch | 2020 | 32801443 | PubTator, text mining | PubMed |
| A three-mRNA status risk score has greater predictive ability compared with a lncRNA-based risk score for predicting prognosis in patients with hepatocellular carcinoma. | Oncol Lett | 2020 | 32788937 | PubTator, text mining | PubMed |
| Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance. | Int J Mol Sci | 2020 | 32781585 | PubTator, text mining | PubMed |
| SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy. | EBioMedicine | 2020 | 32771682 | PubTator, text mining | PubMed |
Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants. | Front Med (Lausanne) | 2020 | 32766265 | PubTator, text mining | PubMed |
| Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting. | Eur J Pharmacol | 2020 | 32745604 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/623/papers?page=35